DILAUDID. INJECTION or DILAUDID-HP in pregnant women. Hydromorphone crosses the placenta, resulting in fetal exposures. DILAUDID INJECTION or DILAUDID-HP
DILAUDID-HP INJECTION is a more concentrated solution of hydromorphone than DILAUDID INJECTION, and is for use in opioid-tolerant patients only. Do not confuse DILAUDID-HP INJECTION with standard parenteral formulations of DILAUDID INJECTION or other opioids, as overdose and death could result.
DILAUDID-HP INJECTION is a more concentrated solution of hydromorphone than DILAUDID INJECTION, and is for use in opioid-tolerant patients only. Do not confuse DILAUDID-HP INJECTION with standard parenteral formulations of DILAUDID INJECTION or other opioids, as overdose and death could result.
DILAUDID INJECTION and DILAUDID-HP INJECTION contain hydromorphone, an route, simultaneously with efforts at respiratory resuscitation.
This Safety Alert highlights significant changes to HYDROmorphone injectable preparations (Dilaudid and Dilaudid HP injections) and advises
DILAUDID-HP INJECTION is a more concentrated solution of hydromorphone than DILAUDID INJECTION, and is for use in opioid-tolerant patients only. Do not confuse DILAUDID-HP INJECTION with standard parenteral formulations of DILAUDID INJECTION or other opioids, as overdose and death could result.
DILAUDID INJECTION is indicated for the management of pain severe enough to DILAUDID INJECTION is contraindicated in patients with significant
Medscape - Pain, analgesia-specific dosing for Dilaudid, Exalgo(hydromorphone) (Dilaudid-HP) injection with the less concentrated (Dilaudid) injectable product
DILAUDID INJECTION and DILAUDID-HP INJECTION contain hydromorphone metabolites. The systemic clearance is approximately 1.96 (20
Comments